Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus.

Prince GA, Jenson AB, Hemming VG, Murphy BR, Walsh EE, Horswood RL, Chanock RM.

J Virol. 1986 Mar;57(3):721-8. Erratum in: J Virol 1986 Jul;59(1):193.

4.

Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses.

Murphy BR, Prince GA, Collins PL, Van Wyke Coelingh K, Olmsted RA, Spriggs MK, Parrott RH, Kim HW, Brandt CD, Chanock RM.

Virus Res. 1988 Aug;11(1):1-15. Review.

PMID:
2845680
5.

An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines.

Murphy BR, Hall SL, Kulkarni AB, Crowe JE Jr, Collins PL, Connors M, Karron RA, Chanock RM.

Virus Res. 1994 Apr;32(1):13-36. Review.

PMID:
8030364
6.

Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease.

Castilow EM, Olson MR, Varga SM.

Immunol Res. 2007;39(1-3):225-39. Review.

PMID:
17917067
7.

Prevention strategies for respiratory syncytial virus: passive and active immunization.

Englund JA.

J Pediatr. 1999 Aug;135(2 Pt 2):38-44. Review.

PMID:
10431138
8.

Immunoprophylaxis of infections with respiratory syncytial virus: observations and hypothesis.

Hemming VG, Prince GA.

Rev Infect Dis. 1990 May-Jun;12 Suppl 4:S470-4; discussion S474-5. Review.

PMID:
2194271

Supplemental Content

Support Center